% alzhub.org topic: antisense-oligonucleotide
% Source: https://alzhub.org/topic/antisense-oligonucleotide
% 16 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{chen2025-40339155,
  author  = {Chen, X. Q. and Zuo, X. and Becker, A. and Mante, M. and Florio, J. B. and Jadhav, S. G. and Albay, R. and Johnstone, A. and others},
  title   = {{Antisense oligonucleotides directed against App and Rab5 normalized endosomal Rab activity and reversed DS-AD-linked degenerative phenotypes in the Dp16 mouse model of Down syndrome}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2025},
  doi     = {10.1002/alz.70022},
  pmid    = {40339155},
  url     = {https://doi.org/10.1002/alz.70022}
}

@article{ahammad2025-40556661,
  author  = {Ahammad, R. U. and Spencer, B. and Quach, B. and Salehi, S. and Rissman, R. A.},
  title   = {{A splice-switching antisense oligonucleotide targeting APP reduces accumulation of α-synuclein in a mouse model of Parkinson's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2025},
  doi     = {10.1002/trc2.70117},
  pmid    = {40556661},
  url     = {https://doi.org/10.1002/trc2.70117}
}

@article{iwataendo2025-40206658,
  author  = {Iwata-Endo, K. and Sahashi, K. and Kawai, K. and Fujioka, Y. and Okada, Y. and Watanabe, E. and Iwade, N. and Ishibashi, M. and others},
  title   = {{Correcting tau isoform ratios with a long-acting antisense oligonucleotide alleviates 4R-tauopathy phenotypes}},
  journal = {Molecular therapy. Nucleic acids},
  year    = {2025},
  doi     = {10.1016/j.omtn.2025.102503},
  pmid    = {40206658},
  url     = {https://doi.org/10.1016/j.omtn.2025.102503}
}

@article{rothstein2023-38019311,
  author  = {Rothstein, J. D. and Baskerville, V. and Rapuri, S. and Mehlhop, E. and Jafar-Nejad, P. and Rigo, F. and Bennett, F. and Mizielinska, S. and others},
  title   = {{G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons}},
  journal = {Acta neuropathologica},
  year    = {2023},
  doi     = {10.1007/s00401-023-02652-3},
  pmid    = {38019311},
  url     = {https://doi.org/10.1007/s00401-023-02652-3}
}

@article{leitao2023-37690676,
  author  = {Leitão, A. D. G. and Ahammad, R. U. and Spencer, B. and Wu, C. and Masliah, E. and Rissman, R. A.},
  title   = {{Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease}},
  journal = {Neurobiology of disease},
  year    = {2023},
  doi     = {10.1016/j.nbd.2023.106285},
  pmid    = {37690676},
  url     = {https://doi.org/10.1016/j.nbd.2023.106285}
}

@article{monine2021-33991294,
  author  = {Monine, M. and Norris, D. and Wang, Y. and Nestorov, I.},
  title   = {{A physiologically-based pharmacokinetic model to describe antisense oligonucleotide distribution after intrathecal administration}},
  journal = {Journal of pharmacokinetics and pharmacodynamics},
  year    = {2021},
  doi     = {10.1007/s10928-021-09761-0},
  pmid    = {33991294},
  url     = {https://doi.org/10.1007/s10928-021-09761-0}
}

@article{chang2018-29628304,
  author  = {Chang, J. L. and Hinrich, A. J. and Roman, B. and Norrbom, M. and Rigo, F. and Marr, R. A. and Norstrom, E. M. and Hastings, M. L.},
  title   = {{Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production}},
  journal = {Molecular therapy : the journal of the American Society of Gene Therapy},
  year    = {2018},
  doi     = {10.1016/j.ymthe.2018.02.029},
  pmid    = {29628304},
  url     = {https://doi.org/10.1016/j.ymthe.2018.02.029}
}

@article{farr2016-27589526,
  author  = {Farr, S. A. and Sandoval, K. E. and Niehoff, M. L. and Witt, K. A. and Kumar, V. B. and Morley, J. E.},
  title   = {{Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2016},
  doi     = {10.3233/jad-160416},
  pmid    = {27589526},
  url     = {https://doi.org/10.3233/jad-160416}
}

@article{magner2015-26544037,
  author  = {Magner, D. and Biala, E. and Lisowiec-Wachnicka, J. and Kierzek, E. and Kierzek, R.},
  title   = {{A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0142139},
  pmid    = {26544037},
  url     = {https://doi.org/10.1371/journal.pone.0142139}
}

@article{jan2015-25957561,
  author  = {Jan, A. and Karasinska, J. M. and Kang, M. H. and de Haan, W. and Ruddle, P. and Kaur, A. and Connolly, C. and Leavitt, B. R. and others},
  title   = {{Direct intracerebral delivery of a miR-33 antisense oligonucleotide into mouse brain increases brain ABCA1 expression. [Corrected]}},
  journal = {Neuroscience letters},
  year    = {2015},
  doi     = {10.1016/j.neulet.2015.05.007},
  pmid    = {25957561},
  url     = {https://doi.org/10.1016/j.neulet.2015.05.007}
}

@article{riboldi2014-24809691,
  author  = {Riboldi, G. and Zanetta, C. and Ranieri, M. and Nizzardo, M. and Simone, C. and Magri, F. and Bresolin, N. and Comi, G. P. and others},
  title   = {{Antisense oligonucleotide therapy for the treatment of C9ORF72 ALS/FTD diseases}},
  journal = {Molecular neurobiology},
  year    = {2014},
  doi     = {10.1007/s12035-014-8724-7},
  pmid    = {24809691},
  url     = {https://doi.org/10.1007/s12035-014-8724-7}
}

@article{farr2014-24577464,
  author  = {Farr, S. A. and Erickson, M. A. and Niehoff, M. L. and Banks, W. A. and Morley, J. E.},
  title   = {{Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2014},
  doi     = {10.3233/jad-131883},
  pmid    = {24577464},
  url     = {https://doi.org/10.3233/jad-131883}
}

@article{erickson2012-22179572,
  author  = {Erickson, M. A. and Niehoff, M. L. and Farr, S. A. and Morley, J. E. and Dillman, L. A. and Lynch, K. M. and Banks, W. A.},
  title   = {{Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2012},
  doi     = {10.3233/jad-2011-111517},
  pmid    = {22179572},
  url     = {https://doi.org/10.3233/jad-2011-111517}
}

@article{benson2010-20462362,
  author  = {Benson, M. D. and Smith, R. A. and Hung, G. and Kluve-Beckerman, B. and Showalter, A. D. and Sloop, K. W. and Monia, B. P.},
  title   = {{Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment}},
  journal = {Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis},
  year    = {2010},
  doi     = {10.3109/13506129.2010.483121},
  pmid    = {20462362},
  url     = {https://doi.org/10.3109/13506129.2010.483121}
}

@article{poon2005-15932783,
  author  = {Poon, H. F. and Farr, S. A. and Banks, W. A. and Pierce, W. M. and Klein, J. B. and Morley, J. E. and Butterfield, D. A.},
  title   = {{Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein}},
  journal = {Brain research. Molecular brain research},
  year    = {2005},
  doi     = {10.1016/j.molbrainres.2005.02.020},
  pmid    = {15932783},
  url     = {https://doi.org/10.1016/j.molbrainres.2005.02.020}
}

@article{majocha1994-7621505,
  author  = {Majocha, R. E. and Agrawal, S. and Tang, J. Y. and Humke, E. W. and Marotta, C. A.},
  title   = {{Modulation of the PC12 cell response to nerve growth factor by antisense oligonucleotide to amyloid precursor protein}},
  journal = {Cellular and molecular neurobiology},
  year    = {1994},
  doi     = {10.1007/bf02088829},
  pmid    = {7621505},
  url     = {https://doi.org/10.1007/bf02088829}
}